Vanderbilt Institute of Nanoscale Science and Engineering awarded VentureWell grant for undergraduate immersion class
Apr. 14, 2021—A new Nanomaker Immersion course coming to Vanderbilt aims to train the next generation of nanotechnology entrepreneurs in a facility rarely utilized by undergraduates. Vanderbilt professor Alice D. Leach will teach nanotech development and commercialization techniques to the next generation of nanotechnology entrepreneurs beginning in fall 2022.
Apr. 9, 2021—An interdisciplinary fellowship with the Data Science Institute has resulted in a promising machine-learning technology that can effectively track complex surgical activity, having the potential to improve patient outcomes, safety and documentation.
Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics
Feb. 25, 2021—A new partnership between Vanderbilt University’s Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will further research into new clinical treatments for multiple obesity syndromes.
Nov. 17, 2020—Further research by biochemistry professors Charles Sanders and Bruce Carter into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves, will be funded by Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt’s innovative life science research.
Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment
Oct. 27, 2020—Jacek Hawiger’s anti-inflammatory peptide therapy, licensed by Amytrx and now in clinical trials, has the potential to safely and effectively treat a multitude of inflammatory and metabolic diseases.
Sep. 22, 2020—Vanderbilt researchers have been awarded a National Science Foundation Convergence Accelerator 2020 Cohort Phase 1 grant to create a standardized platform that will streamline the development, testing and dissemination of technology that can improve human health. The nine-month project, “Scalable, Traceable AI for Imaging Translation: Innovation to Implementation for Accelerated Impact (STRAIT I3),” looks specifically...
Tiny tweezer developed at Vanderbilt can trap molecules on a nanoscale, creating powerful research capabilities into cancer metastasis, neurodegenerative diseases
Aug. 31, 2020—Working on a minuscule scale, a new nanotweezer successfully captures and sorts individual proteins and DNA without harming their function, for myriad applications in life science research.
Aug. 28, 2020—Single-cell and multisystem analysis leads cell biologists at Vanderbilt to new understanding of rare cells, with potential inflammation-reducing therapeutics for Crohn’s disease and IBD patients.
Aug. 19, 2020—A bifunctional natural compound has been discovered with the potential to make antibiotic resistance to deadly infections less likely.
Center for Technology Transfer & Commercialization breaks records in rapid facilitation of COVID-19 related agreements
Jul. 9, 2020—To keep pace with Vanderbilt researchers developing COVID-19 solutions, the Center for Technology Transfer & Commercialization has facilitated three license agreements, 11 patent applications and 43 material transfer agreements in record time.
Jul. 6, 2020—Vanderbilt University is ranked 36th in a 2019 U.S. patents report released by the by the National Academy of Inventors and the Intellectual Property Owners Association.
Nov. 14, 2019—A new continuum robot designed by Vanderbilt engineers achieves multiscale motion and may open up a huge world of previously impossible complex microsurgeries.